(Q54373157)

28 May 2018

title

Treatment with brain natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db/db mice. (English)

1 reference

28 May 2018

0 references

6

Jolanta Gutkowska

1 reference

28 May 2018

Bogdan A Danalache

3

object named as

Bogdan A Danalache

1 reference

28 May 2018

author name string

Eric Plante

1

1 reference

28 May 2018

Ahmed Menaouar

2

1 reference

28 May 2018

Tom L Broderick

4

1 reference

28 May 2018

Marek Jankowski

5

1 reference

28 May 2018

publication date

5 March 2014

1 reference

28 May 2018

published in

Diabetologia

1 reference

28 May 2018

volume

57

1 reference

28 May 2018

issue

6

1 reference

28 May 2018

page(s)

1257-1267

1 reference

28 May 2018

Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Impact of obesity on plasma natriuretic peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Oxidant-induced pHi/Ca2+ changes in rat aortic smooth muscle cells. The role of atrial natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

The role of natriuretic peptides in cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Diabetic cardiomyopathy: the search for a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Brown adipose tissue: function and physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Natriuretic peptide testing in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Functional evidence for an active role of B-type natriuretic peptide in cardiac remodelling and pro-arrhythmogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Effect of nesiritide in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Effects of DPP-4 inhibition on cardiac metabolism and function in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Complexity of molecular forms of B-type natriuretic peptide in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Targeting myocardial substrate metabolism in heart failure: potential for new therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Cyclic GMP signaling in cardiomyocytes modulates fatty acid trafficking and prevents triglyceride accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3201-4

ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 199

21 January 2018

1 reference

12 December 2020

Oxidative stress in diabetes.

1 reference

12 December 2020

The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages.

1 reference

12 December 2020

Regulation of atrial natriuretic peptide gene expression in gastric antrum by fasting.

1 reference

12 December 2020

10.1007/S00125-014-3201-4

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018